For example, glypican-1 in circulating exosomes demonstrated discrimination between PDAC patients and healthy controls with 100% sensitivity and specificity; however, breast cancer patients also display high values indicating insufficient PDAC specificity [18]. This evidence concerns the gene GPC1 and breast cancer.